BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32425063)

  • 1. Renal calcitonin amyloidosis in a patient with disseminated medullary thyroid carcinoma.
    Tan Y; Li DY; Ma TT; Xu R; Zhou FD; Wang SX; Zhao MH
    Amyloid; 2020 Sep; 27(3):213-214. PubMed ID: 32425063
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: A systematic review.
    Trimboli P; Guidobaldi L; Bongiovanni M; Crescenzi A; Alevizaki M; Giovanella L
    Diagn Cytopathol; 2016 Jan; 44(1):45-51. PubMed ID: 26481456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma.
    Trimboli P; Lauretta R; Barnabei A; Valabrega S; Romanelli F; Giovanella L; Appetecchia M
    Int J Biol Markers; 2018 May; 33(2):156-160. PubMed ID: 29707993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary localized cutaneous amyloidosis and familial medullary thyroid carcinoma.
    Ferrer JP; Halperin I; Conget JI; Alsina M; Martinez-Osaba MJ; Palou J; Bombi JA; Vilardell E
    Clin Endocrinol (Oxf); 1991 Jun; 34(6):435-9. PubMed ID: 1889128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney Involvement in Systemic Calcitonin Amyloidosis Associated With Medullary Thyroid Carcinoma.
    Koopman T; Niedlich-den Herder C; Stegeman CA; Links TP; Bijzet J; Hazenberg BPC; Diepstra A
    Am J Kidney Dis; 2017 Apr; 69(4):546-549. PubMed ID: 28024929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
    Karagiannis AK; Girio-Fragkoulakis C; Nakouti T
    Anticancer Res; 2016 Aug; 36(8):3803-10. PubMed ID: 27466480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
    Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
    Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Prox1 in Medullary Thyroid Carcinoma Is Associated with Chromogranin A and Calcitonin Expression and with Ki67 Proliferative Index, but Not with Prognosis.
    Saglietti C; La Rosa S; Sykiotis GP; Letovanec I; Bulliard JL; Piana S; Mermod M; Petrova T; Uccella S; Sessa F; Bongiovanni M
    Endocr Pathol; 2019 Jun; 30(2):138-145. PubMed ID: 31001799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcitonin-producing neuroendocrine carcinoma of the larynx: atypical carcinoid tumor].
    Morales C; Tomás Bezos J; Alvarez-Quiñones Sanz M; García Mantilla J; Carrera F
    Acta Otorrinolaringol Esp; 1996; 47(4):333-5. PubMed ID: 8962741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing medullary thyroid carcinoma is facilitated by measuring calcitonin in FNA washout fluids: Alea iacta est.
    Trimboli P; Crescenzi A
    Cancer Cytopathol; 2024 Mar; 132(3):139. PubMed ID: 38324164
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of Medullary Thyroid Cancer.
    Viola D; Elisei R
    Endocrinol Metab Clin North Am; 2019 Mar; 48(1):285-301. PubMed ID: 30717909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
    Simms A; Jacob RP; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Unusual Case of Medullary Thyroid Carcinoma and A Revision of Current Literature.
    Cipri C; Vescini F; Torresan F; Pennelli G; Pelizzo MR; Triggiani V; Guastamacchia E; Grimaldi F
    Endocr Metab Immune Disord Drug Targets; 2019; 19(2):226-229. PubMed ID: 30574858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and validation of miRNAs as normalizers for profiling expression of microRNAs isolated from thyroid fine needle aspiration smears.
    Titov SE; Demenkov PS; Ivanov MK; Malakhina ES; Poloz TL; Tsivlikova EV; Ganzha MS; Shevchenko SP; Gulyaeva LF; Kolesnikov NN
    Oncol Rep; 2016 Nov; 36(5):2501-2510. PubMed ID: 27666315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.
    Song H; Lin C; Yao E; Zhang K; Li X; Wu Q; Chuang PT
    J Biol Chem; 2017 Mar; 292(9):3888-3899. PubMed ID: 28119454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medullary carcinoma of the thyroid.
    Corwin TR
    Surg Gynecol Obstet; 1974 Mar; 138(3):453-8. PubMed ID: 4590286
    [No Abstract]   [Full Text] [Related]  

  • 17. Medullary thyroid carcinoma detected by serum calcitonin assay.
    Block MA; Jackson CE; Tashjian AH
    Arch Surg; 1972 Apr; 104(4):579-86. PubMed ID: 5013799
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progression of diagnosis and treatment of medullary thyroid carcinoma].
    Wang X; Li C; Huang L; Shui CY; Liu W; Cai YC; Sun RH; Zhou YQ; Jiang J; Wang W; Zeng DF
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Apr; 54(4):306-310. PubMed ID: 30991785
    [No Abstract]   [Full Text] [Related]  

  • 19. Proceedings: Medullary carcinoma of the thyroid gland.
    Hill CS
    Proc Natl Cancer Conf; 1972; 7():163-77. PubMed ID: 4203017
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cancer of thyroid gland with amyloidosis of the stroma].
    Sidel'man KN
    Arkh Patol; 1970; 32(5):38-43. PubMed ID: 5449116
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.